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A 13-residue peptide corresponding to a hydrophobic segment of the antimicrobial 47-residue peptide
seminalplasmin, PKLLETFLSKWIG (SPF), has been shown to have antibacterial and hemolytic activities (N.
Sitaram and R. Nagaraj, J. Biol. Chem. 265:10438-10442, 1990). In an effort to get an insight into the
structural and charge requirements for these biological activities, an analog of SPF in which Glu has been
replaced with Lys has been synthesized and its antibacterial and hemolytic properties have been examined. It
has been demonstrated that the analog, SPFK, exhibits potent antibacterial activity at concentrations at which
hemolysis does not occur.
There has been considerable interest in recent years in
structure-function studies with peptides composed of 15 to
30 residues and possessing antibacterial and eukaryotic cell
lytic activities (2, 4-9, 13, 15, 16, 18, 20, 22-27). One aspect
of these studies has been the evaluation of shorter segments
of these peptides for biological activity (1, 6, 12, 14, 21). In
addition to defining the minimal requirements for biological
activity, these peptides can prove to be helpful in possible
therapies, since short peptides are easy to generate by
chemical synthesis. We have previously demonstrated that
a hydrophobic 13-residue segment, PKLLETFLSKWIG
(SPF), of the antimicrobial 47-residue peptide seminalplas-
min (SPLN), has antibacterial activity as well as erythrocyte
lytic activity (26). SPF was shown to adopt an amphipathic
helical structure with two Lys and one Glu residue on the
polar face of the helix. Thus, SPF has a net positive charge
of + 1 at neutral pH. In an effort to get an insight into the
structural and charge requirements for biological activity,
we have synthesized SPFK, an analog of SPF in which Glu
has been replaced by Lys. Thus, SPFK would have a net
charge of +3 at neutral pH. In this report, we show that
SPFK exhibits potent antibacterial activity at concentrations
at which erythrocyte lysis does not occur.
MATERIALS AND METHODS
Peptide synthesis. The synthesis of SPF has been reported
previously (26). Peptide SPFK was synthesized on triethyl-
eneglycoldimethacrylate-cross-linked (1%) polystyrene resin
by using t-Boc chemistry and protocols essentially as de-
scribed for SPF (26). The peptide was characterized by
amino acid analysis and sequencing on an Applied Biosys-
tems 473A instrument.
Antibacterial activities. The MICs of the peptides were
determined by incubating a logarithmically growing culture
of Escherichia coli W160.37 in a minimal synthetic medium
[0.5 g of NH4C1, 0.5 g of (NH4)2SO4, 13.6 g of KH2PO4, 0.02
g of MgSO4. 7H20, 0.015 g of (NH4)2Fe(SO4)2 6H20, 20 g
of glucose, 0.1 g of L-arginine hydrochloride in 1 liter of
medium (pH 7.2)] diluted to an initialA6. of 0.01, at 37°C for
* Corresponding author.
6 h in the absence and presence of various concentrations of
the peptides. An A6. of 0.5 to 0.6 was observed for the
control culture, which contained no peptide, and this value
was taken to be 100%. The effect of divalent cations was
determined by performing the assay in the presence of
various concentrations of cations.
Bacteriolytic activity was monitored by measuring the
activity of (3-galactosidase released from E. coli W160.37
cells grown to logarithmic phase in the above medium
containing 5 x 10' M isopropylthiogalactopyranoside (17)
and incubated in the absence and presence of the peptides at
37°C. The A6. of the culture before the peptide was added
was 0.2 to 0.3 (2.0 x 108 to 3.0 x 108 cells per ml). Aliquots
of 150 pl were withdrawn at different times, diluted to 1 ml
with ice-cold assay buffer (0.06 M Na2HPO4, 0.04 M
NaH2PO4, 0.01 M KCI, 0.001 M MgSO4, 0.05 M P-mercap-
toethanol, pH 7.4) and spun down at 12,000 x g at 4°C.
1-Galactosidase activity in the supernatant was measured
using ortho-nitrophenylgalactopyranoside (ONPG) as sub-
strate. In order to determine the permeability properties of
the bacterial inner membrane in the presence of the peptide,
the influx of ONPG into sedimented cells described above
was determined by incubating the cells with ONPG in 1 ml of
assay buffer at 37°C. The total enzyme activity in the
sedimented cells in the absence of the peptide was measured
after the cells were treated with a few drops of 0.1% sodium
dodecyl sulfate (SDS)-chloroform. The effect of cations was
determined by incubating the cells with the peptides in the
absence and presence of various concentrations of cations.
Hemolytic activity. Rat erythrocytes were isolated by
centrifugation of freshly collected blood followed by three
washes with 5 mM HEPES (N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid) buffer (pH 7.4) containing 150 mM
KCI to remove the buffy coat. Erythrocytes (0.5% [vol/vol])
were incubated at 37°C in the same buffer with different
concentrations of the peptide for 15 min at 37°C. Samples
were centrifuged, and the A540 in the supematant was
measured. The absorbance obtained by treatment of eryth-
rocytes with 1% Triton X-100 was taken to be 100%.
The effect of transmembrane potential on hemolysis was
determined by preparing the cells as described above with 5
mM HEPES (pH 7.4)-150 mM KCI but suspending them in
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TABLE 1. Antibacterial activities of peptides
Concn of % Inhibition of growth of E. coli by:
peptide(pLg/ml) SPFK SPF SPLN
4 67 0
6.6 84 0
10 100 0 15
20 100 25 95
30 100 60 100
40 100 90 100
50 100 100 100
5 mM HEPES (pH 7.4)-150 mM NaCl buffer for the assay.
Three microliters of 1.6 mM valinomycin solution dissolved
in dimethyl sulfoxide was added to 0.75 ml of the erythrocyte
suspension. After 20 s, 0.5 ml of this cell suspension was
mixed with an equal volume of peptide containing buffer of
the same composition. The samples were incubated for 15
min and cells were spun down for estimation of hemolysis.
The potential induced was checked by using a potential-
sensitive dye, 3,3'-dipropylthiocarbocyanine [diSC3-(5)],
according to the method of Sims et al. (23). The experiment
performed in the absence of valinomycin was taken to be the
control.
RESULTS AND DISCUSSION
Antibacterial activity. The percent inhibition of growth of
E. coli W160.37 cells in logarithmic phase during incubation
with different concentrations of SPFK was compared with
the effects of SPF and SPLN. The results are summarized in
Table 1. The MIC of SPFK is 10 ,ug/fml, compared with 50
,ug/ml for SPF and 30 ,ug/ml for SPLN. SPFK is clearly more
potent as an antibacterial agent than SPF or SPLN. The
antibacterial activities of SPF and SPLN have been previ-
ously shown to arise from their ability to alter the perme-
ability properties of the bacterial inner membrane (25, 26).
Hence, the bacteriolytic activity of SPFK and its effect on
the permeability properties of the bacterial inner membrane
were studied. The influx of ONPG into sedimented E. coli
cells as a function of time and peptide concentration is
shown in Fig. 1. Considerable ONPG influx is discernible,
even at peptide concentrations of 20 ,tg/ml. At 40 ,ug/ml and
above, the influx is rapid and in 15 min the inner membrane
no longer acts as a permeability barrier. Interestingly, no
3-galactosidase activity could be detected in the cell-free
supernatant even when the inner membrane was completely
permeabilized. This rapid concentration-dependent en-
hancement of ONPG influx in the presence of SPFK indi-
cates the opening of other pathways for the influx of ONPG
through the bacterial inner membrane in addition to the
transporter lac permease and is the cause of cell death. The
concentration of SPFK required to permeabilize the bacte-
rial inner membrane is less than that observed for SPF and
SPLN, indicating that increased cationicity may enhance the
membrane-perturbatory property of the peptide.
We have previously shown that the divalent cations Ca2+,
Mn2+, and Zn2+ can inhibit the antibacterial activity of
SPLN against E. coli by stabilizing the bacterial membrane
(25). We have investigated the effect of Ca2" ions on
antibacterial activity and on membrane permeability changes
brought about by SPF and SPFK. It can be seen from Fig. 2a
that 600 ,uM Ca2+ can almost completely abolish the anti-
X 80
-1J
U-
z
(D60
0.
z
040
0-
20
5 10 15 20
TIME (Min)
FIG. 1. Effect of SPFK on the influx of ONPG into E. coli
W160.37. E. coli cells in thl. logarithmic phase of growth with an
initial absorbance of 0.3 were incubated with the following concen-
trations (in micrograms per milliliter) of peptide: 0 (0), 20 (0), 40
(0), and 60 (U). Aliquots were withdrawn at different time points,
and ONPG influx into cells was determined as discussed in Materials
and Methods.
bacterial activity of SPF and SPFK. The enhancement of
bacterial inner membrane permeability with ONPG by SPF
and SPFK is also inhibited by Ca2" (Fig. 2b). Similar results
were obtained with the other divalent cations Mn2' and
Zn2+. These results indicate that SPFK perturbs the bacte-
rial outer membrane, enters the cells, and then acts on the
inner membrane. The increased cationic nature of SPFK
may favor an association with acidic components of the
bacterial outer membrane and subsequent entry into the
inner membrane. Inhibition of antibacterial activity by cat-
ions also rules out receptor-mediated entry through the outer
membrane (3) or through porins (19). Although SPLN has
four positive charges (24), these are distributed throughout
the polypeptide chain and not in the region of SPF (26),
which is an important determinant of activity.
Hemolytic activity. The hemolysis of rat erythrocytes by
SPFK as a function of peptide concentration was investi-
gated. Hemolysis was discernible above a concentration of 9
,uM. The antimicrobial and hemolytic activities of SPF and
SPFK are compared in Fig. 3. In the case of SPFK,
considerable antibacterial activity is discernible even at a
concentration of 3 ,uM, at which virtually no hemolysis is
observed, and at 9 ,uM 100% antibacterial activity is ob-
served with only 10% hemolytic activity. SPF under similar
conditions does not show differences in its hemolytic and
antibacterial activities. Thus, the Glu--Lys change has
resulted in the peptide exhibiting antibacterial activity at
concentrations at which erythrocyte lysis does not occur.
Thus, by judicious choice of charge replacements it may be
possible to alter the cell lytic properties of peptides and
obtain selectivity for either prokaryotic or eukaryotic cells.
In addition to hydrophobicity of the peptide, charge on the
peptide, and surface charge on the membrane, another
important parameter likely to influence the interaction of the
VOL. 36, 1992
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FIG. 2. Effect of cations on antibacterial activity and ONPG influx. (a) Antibacterial activity of 7 Fg of SPFK per ml (0) and 40 Lg of SPF
per ml (0). (b) ONPG influx with 40 p,g of SPFK per ml (0) and 80 ,ug of SPF per ml (-).
peptide with biomembranes is the electrochemical potential
existing across the membrane. Transmembrane potentials
have been shown to influence the association of hydrophobic
peptides with membranes (10, 11). It has also been shown
that hemolysis by a 25-residue presequence peptide of sub-
unit IV of the Saccharomyces cervisiae cytochrome oxidase
and its effect on the leakage of entrapped carboxyfluorescein
from small unilammelar vesicles increase in a potential-
dependent manner (8). Hence, we investigated whether the
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FIG. 3. Comparison of antibacterial and hemolytic activities of
SPFK and SPF. Symbols: 0, antibacterial activity SPFK; 0,
hemolytic activity of SPFK; *, antibacterial activity of SPF; El,
hemolytic activity of SPF.
presence of transmembrane potential has any effect on
hemolysis by SPF and SPFK. The hemolytic profiles of both
SPF and SPFK, in the presence and absence ofvalinomycin,
are presented in Fig. 4. It is clear from the figure that the
presence of transmembrane potential decreases the thresh-
old concentration of the peptide required to cause hemoly-
sis. However, the antibacterial activity of SPFK is apprecia-
bly more than its hemolytic activity even in the presence of
a membrane potential.
The circular dichroic spectra of SPFK in buffer and SDS
E PEPTIDE 3 (,uM)
FIG. 4. Effect of transmembrane potential on the hemolytic
activities of SPFK and SPF. Symbols: 0 and 0, hemolytic activities
of SPFK and SPF, respectively, in the absence of valinomycin;-
and *, hemolytic activities of SPFK and SPF, respectively, in the
presence of valinomycin.
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FIG. 5. Circular dichroic spectra of SPFK in (a) buffer at pH 7.4 and (b) micelles of SDS. Spectra were recorded on a Jobin Yvon
Dicro-graph V spectropolarimeter at 25°C in cells with a path length of 0.1 cm. [O]M values are mean residue elipticities.
micelles are shown in Fig. 5. The spectra indicate that SPFK
adopts a helical conformation, particularly in a hydrophobic
environment. SPF has been shown to adopt a helical con-
formation in a hydrophobic environment (26). The mean
residue ellipticities at 222 nm are comparable for both
peptides. The helical wheel projections of SPF and SPFK
are shown in Fig. 6. The values for average hydrophobicity
and hydrophobic moment for SPF were 0.24 and 0.41 and for
SPFK were 0.18 and 0.42. It is evident that the change of
Glu-.Lys does not result in drastic changes in hydrophobic
moment or average hydrophobicity. Hence, the differences
in activities of SPFK and SPF are not due to differences in
structure.
The data presented in this report demonstrate that replace-
ment of glutamic acid of SPF with lysine results in consid-
erably enhanced antibacterial activity of the peptide without
a concomitant increase in erythrocyte lytic activity. This
enhancement of antibacterial activity stems primarily from
the increased net positive charge on the peptide, as this
modification does not bring about significant changes in its
hydrophobicity, hydrophobic moment, or conformation
compared with SPF. Interestingly, increased cationicity
does not result in the peptide being more hemolytic, as
interaction with the negative surface of the erythrocyte
membrane would also be favored. Thus, cationic charges
clearly play a more important role in interactions with the
bacterial membrane. Although cationic antibacterial, nonhe-
molytic peptides have been isolated from amphibian skin and
insects (7, 18, 25, 27, 28), they are considerably longer (25 to
37 residues). Also, in magainins, a reduction in the length of
the peptide chain leads to a considerable loss in antimicro-
bial activity (7, 28). Hence, studies directed toward struc-
ture-function correlation with short bioactive peptides such
as SPF and SPFK, which are composed of only 13 residues
Pro I
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FIG. 6. Helical wheel projections of SPF and SPFK. Polar residues are underlined.
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and thus are easily obtainable by chemical synthesis, would
be appropriate for possible therapeutic uses.
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